4//SEC Filing
Bellon Steven F. 4
Accession 0001562180-22-006087
CIK 0001822462other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 6:15 PM ET
Size
8.0 KB
Accession
0001562180-22-006087
Insider Transaction Report
Form 4
Bellon Steven F.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-11$3.72/sh+1,858$6,912→ 121,957 total - Exercise/Conversion
Stock Options (Right to buy)
2022-08-11−1,858→ 3,716 totalExercise: $3.72Exp: 2029-02-12→ Common Stock (1,858 underlying)
Holdings
- 50,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
- [F2]The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831749
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 6:15 PM ET
- Size
- 8.0 KB